DeepMind, the AI-focused subsidiary of Google, has officially open-sourced AlphaFold 3, the latest version of its revolutionary protein structure prediction tool.

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.